LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Method Created Based On Birefringence

By LabMedica International staff writers
Posted on 20 Dec 2015
Image: The birefringence pattern of a sample positive to Ebolavirus infection (Photo courtesy of Jijo Vallooran /ETH Zurich).
Image: The birefringence pattern of a sample positive to Ebolavirus infection (Photo courtesy of Jijo Vallooran /ETH Zurich).
A new diagnostic method has been created based on birefringence, which is the ability of substances to change the polarization state of light. With this method, doctors around the world could easily, rapidly, and reliably detect pathogenic microorganisms.

Although the concept behind this new technology is very general and appears so easy to operate, the scientific basis underlying the invention is extremely complex. The phenomenon of birefringence of polarized light from the lipid based lyotropic liquid crystals, which consist of self-assembled structures of fat molecules in water.

Scientists at the Swiss Federal Institute of Technology (ETH; Zurich; Switzerland) used lipidic cubic phases that are optically isotropic, transparent lyotropic liquid crystals (LC), containing highly confined water nanochannels in-between percolating lipid bilayers following defined space groups. Due to this nano-confinement, the water in these systems provides a unique environment for chemical and enzymatic reactions.

During the mesoperoxidase enzymatic reaction, the converted product crystallizes within the mesophase domains, generating a detectable birefringence signal and a new general assay principle is presented for the detection of an unprecedented vast class of analytes using such birefringence as sole optical output signal. The team used polarized light microscopy and a small amount of the cubic phase was analyzed under cross-polarized light using an Axioskop 2 MOT microscope (Zeiss; Oberkochen, Germany) at 37 °C. The polarization device costs CHF 20, which considerably less expensive when compared with other detection methods.

By exploiting bienzymatic cascade reactions or introducing an enzyme-linked immunosorbent assay based on birefringence (Birefringent-ELISA), this approach was used for real-time detection of exemplary analytes, such as glucose and cholesterol, model pathogenic microorganisms, Escherichia coli, and viruses such as Ebola and human immunodeficiency virus (HIV). The team also showed how the same technology enables the rapid, naked-eye screening of malaria infection via in meso detection of hemozoin crystallites. Pathogens can be detected very rapidly, and a reliable result received within less than an hour.

Raffaele Mezzenga, PhD, a professor and lead author of the study said, “The Plasmodium parasite invades erythrocytes and digests hemoglobin. The heme component, which is toxic to the parasites, is crystallized and thus has inherently birefringent surfaces. So it's not necessary to mark it with antibodies and no enzymatic reaction is required.” The study was published in the November 2015 issue of the journal Advanced Functional Materials.

Related Links:

Swiss Federal Institute of Technology 
Zeiss 


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more